Heron Bay Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16M Sell
30,284
-20,009
-40% -$9.23M 1.45% 23
2026
Q1
$24.2M Buy
50,293
+30,862
+159% +$15.8M 2.23% 17
2025
Q4
$10.9M Sell
19,431
-195
-1% -$111K 2.08% 19
2025
Q3
$10.1M Sell
19,626
-14
-0.1% -$6.11K 1.88% 19
2025
Q2
$6.16M Buy
19,640
+57
+0.3% +$17.1K 1.21% 28
2025
Q1
$5.97M Buy
+19,583
New +$6.59M 1.25% 26
2024
Q4
Sell
-643
Closed -$215K 123
2024
Q3
$215K Hold
643
0.05% 80
2024
Q2
$265K Hold
643
0.06% 72
2024
Q1
$260K Buy
+643
New +$226K 0.06% 76

Other funds holding MEDP

Heron Bay Capital Management's MEDP Position: Q2 2026 in Review

Heron Bay Capital Management reduced its Medpace (MEDP) stake by 40% in Q2 2026, selling an estimated $9.23M and leaving 30,284 shares worth $16M. The position accounts for 1.45% of the portfolio, ranked #23.

Heron Bay Capital Management first reported a position in MEDP in Q1 2024 and has held it in 9 quarters since. The position peaked at $24.2M in Q1 2026. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Heron Bay Capital Management held 30,284 shares of Medpace worth $16M as of Q2 2026.
  • Heron Bay Capital Management sold 20,009 Medpace shares in Q2 2026, an estimated $9.23M.
  • Medpace made up 1.45% of Heron Bay Capital Management's portfolio in Q2 2026, its #23 holding.
  • Heron Bay Capital Management first reported a position in Medpace in Q1 2024 and has held it in 9 quarters since.
  • Heron Bay Capital Management's Medpace position peaked at $24.2M in Q1 2026.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Heron Bay Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.